How magnets could be used to guide cancer-killing drugs to tumors
There is much research in progress, seeking efficient ways to get anti-cancer drugs to tumors — using magnets.
There is much research in progress, seeking efficient ways to get anti-cancer drugs to tumors — using magnets.
A new study finds that a disrupted gut microbiome alters mast cells, or immune cells in breast tissue, which ultimately helps cancer spread.
Inhibiting a protein called the GABAA receptor protects the gut from experiencing the toxic aftermath of a chemotherapy or radiotherapy session.
A new study from the University of Chicago reports that commensal bacteria encourage leukemia caused by the murine leukemia virus (MuLV) by suppressing the anti-tumor immune response in mice.
A new study conducted by Emory University researchers explores this in mice with malignant melanoma, finding that broad-spectrum antibiotics decreases gut diversity in the rodents.
A Mayo Clinic research team has used artificial intelligence (AI) to generate an algorithm to get ahead on detecting colorectal cancer resurgence.
A new study, from the Tokyo University of Science (TUS) reports on an antibody and an immunoreceptor protein with roles in reducing colitis severity and colon tumor growth.
Researchers from the Wellcome Trust Sanger Institute have created the first-ever map of immune system connections.
People with an inherited form of cancer called Lynch syndrome, who eat high amounts of resistant starch, showed a significant reduction in cancer found in multiple parts of the body.
Johns Hopkins research suggests that C. diff infections may contribute to the rise of colorectal cases in young Americans.